![Scott M. Plesha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Scott M. Plesha
No open positions remaining
Net worth: 671 663 $ as of 31/08/2026
Profile
Scott M.
Plesha is currently Chief Executive Officer at LNHC, Inc. since 2023 and President, Chief Executive Officer & Director at Pelthos Therapeutics, Inc. starting in 2025.
Formerly, Mr. Plesha was Sales Manager-OClassen Dermatologics Division at Actavis, Inc. from 1998 to 2000, Senior Vice President-Sales Force & Training at Salix Pharmaceuticals Ltd. from 2011 to 2015, and President & Chief Commercial Officer at BioDelivery Sciences International, Inc. from 2018 to 2022.
Mr. Plesha completed undergraduate education at DePauw University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
0.8% | 15/07/2026 | 27,893 ( 0.8% ) | 671 663 $ | 31/08/2026 |
Scott M. Plesha active positions
| Companies | Position | Start |
|---|
Former positions of Scott M. Plesha
| Companies | Position | End |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | President | 22/03/2022 |
| SALIX PHARMACEUTICALS, LTD. | Corporate Officer/Principal | 01/04/2015 |
Actavis, Inc.
 Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Sales & Marketing | 01/09/2000 |
Training of Scott M. Plesha
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
50
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Actavis, Inc.
Actavis, Inc. Pharmaceuticals: MajorHealth Technology Manufactures generic, brand and biologic pharmaceutical products | Health Technology |
Salix Pharmaceuticals Ltd.
 Salix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company for the prevention and treatment of gastrointestinal diseases & disorders | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
DePauw University
 DePauw University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Scott M. Plesha
